USC
USC Center Testing Efficacy of Colorectal Cancer, Genetic Risk Education in Hispanic Community
Premium
In the trial, researchers will evaluate whether educational materials and talks increase knowledge and healthy lifestyles among community members.
Denovo Biopharma, Anova Get $11.8M Grant to Study Biomarker-Guided Gene Therapy in Glioma Patients
Denovo, Anova, and academic partners will put the funds toward studying DB107 in certain gliomas.
ACMG Statement Says Preimplantation Polygenic Risk Testing 'Not Appropriate for Clinical Use' Yet
Overall, the organization remains skeptical of the clinical implementation of PRS testing, pointing to limitations of the tests and a lack of evidence for their clinical utility.
The FDA's approval of Novartis' Pluvicto and the imaging agent Locametz for PSMA-positive mCRPC has implications for cancer centers and other drugmakers in the radiopharmaceutical space.
USC Opens Phase II Trial of Ambrx's ARX788 for HER2-Positive Breast Cancer
The trial will evaluate metastatic, pretreated breast cancer patients' overall response rates on the HER2-directed antibody-drug conjugate.